EUVIMEDEUVIMED entdecken
Crossref

Weight Change When Initiating, Switching to, and Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV

Warittha Tieosapjaroen iD, Eric P F Chow iD, Christopher K Fairley, Jennifer Hoy, Ivette Aguirre, Jason J Ong

AIDS Patient Care and STDs · 01.03.2023 · 37 (3) · 131-137

DOI: 10.1089/apc.2022.0203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS Patient Care and STDs, erschienen am 01.03.2023. Verfasst von Warittha Tieosapjaroen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Melbourne Sexual Health Centre, Alfred Health, Carlton, Australia. Hauptthemen laut MEDLINE: HIV Infections, HIV Integrase Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Further investigations into the relationship between integrase strand transfer inhibitors (INSTIs) and weight gain are required, especially whether ceasing INSTI results in weight loss. We evaluated weight changes associated with different antiretroviral (ARV) regimens. A retrospective longitudinal cohort study was conducted using data extracted from the electronic clinical database at the Melbourne Sexual Health Centre, Australia, from 2011 to 2021. The association between weight change per time unit and ARV use in people living with HIV (PLWH) and the factors associated with weight changes when using INSTIs were estimated using a generalized estimated equation model. We included 1540 PLWH contributing 7476 consultations and 4548 person-years of data. ARV-naive PLWH initiating INSTIs gained an average of 2.55 kg/year (95% confidence interval 0.56 to 4.54; p = 0.012), while those using protease inhibitors and non-nucleoside reverse transcriptase inhibitors had no significant weight change. When switching off INSTIs, there was no significant weight change (p = 0.055). These weight changes were adjusted for age, gender, time on ARVs, and/or use of tenofovir alafenamide (TAF). Weight gain was the main reason PLWH ceased INSTIs. In addition, risk factors for weight gain in INSTI users were age younger than 60 years, male gender, and concomitant use of TAF. Weight gain was found among PLWH using INSTIs. After INSTI discontinuation, PLWH's weight stopped rising, but no weight loss was observed. Careful weight measurement after initiating INSTIs and early initiation of strategies to avoid weight gain will be important to prevent permanent weight gain and the associated morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV Integrase InhibitorsHumansMaleMiddle AgedRetrospective StudiesLongitudinal StudiesAnti-Retroviral AgentsWeight GainIntegrases

Stichwörter der Autor:innen

HIVadverse effectsantiretroviral agentsintegrase inhibitorsobesityweight gain

Substanzen

HIV Integrase InhibitorsAnti-Retroviral AgentsIntegrases

Autor:innen und Institutionen

  • Melbourne Sexual Health Centre, Alfred Health, Carlton, Australia.
  • Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
  • Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Department of Infectious Diseases, Alfred Hospital, Melbourne, Australia.
  • Faculty of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.

ORCID-Profile: Warittha Tieosapjaroen, Eric P F Chow

Zitieren

APA

Tieosapjaroen, W., Chow, E. P. F., Fairley, C. K., Hoy, J., Aguirre, I., & Ong, J. J. (2023). Weight Change When Initiating, Switching to, and Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV. AIDS Patient Care and STDs, 37(3), 131-137. https://doi.org/10.1089/apc.2022.0203

Vancouver

Tieosapjaroen W, Chow EPF, Fairley CK, Hoy J, Aguirre I, Ong JJ. Weight Change When Initiating, Switching to, and Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV. AIDS Patient Care and STDs. 2023;37(3):131-137. doi:10.1089/apc.2022.0203

BibTeX
@article{Tieosapjaroen2023,
  author = {Tieosapjaroen, Warittha and Chow, Eric P F and Fairley, Christopher K and Hoy, Jennifer and Aguirre, Ivette and Ong, Jason J},
  title = {Weight Change When Initiating, Switching to, and Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV},
  journal = {AIDS Patient Care and STDs},
  year = {2023},
  volume = {37},
  number = {3},
  pages = {131--137},
  doi = {10.1089/apc.2022.0203}
}
Kostenlos starten →